Insider Transactions in Q1 2023 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Open market or private sale
|
Direct |
15,098
-4.15%
|
$6,688,414
$443.63 P/Share
|
|
Mar 09
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
2,314
-13.12%
|
$1,069,068
$462.22 P/Share
|
|
Mar 02
2023
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
380
-11.65%
|
$177,840
$468.78 P/Share
|
|
Mar 02
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-5.79%
|
$507,312
$468.78 P/Share
|
|
Mar 02
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
5,430
-7.55%
|
$2,541,240
$468.78 P/Share
|
|
Mar 02
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-12.45%
|
$2,224,872
$468.78 P/Share
|
|
Mar 02
2023
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,650
-6.8%
|
$2,176,200
$468.78 P/Share
|
|
Mar 02
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
5,469
-23.41%
|
$2,559,492
$468.78 P/Share
|
|
Mar 02
2023
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,614
-11.48%
|
$8,243,352
$468.78 P/Share
|
|
Mar 01
2023
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,717
+17.25%
|
-
|
|
Mar 01
2023
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-4.49%
|
$174,468
$469.03 P/Share
|
|
Mar 01
2023
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+18.1%
|
-
|
|
Mar 01
2023
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-3.34%
|
$30,016
$469.03 P/Share
|
|
Mar 01
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
4,568
+11.54%
|
-
|
|
Mar 01
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-2.03%
|
$137,417
$469.03 P/Share
|
|
Mar 01
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
BUY
Grant, award, or other acquisition
|
Direct |
11,849
+7.6%
|
-
|
|
Mar 01
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
617
-1.02%
|
$289,373
$469.03 P/Share
|
|
Mar 01
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
12,008
+13.86%
|
-
|
|
Mar 01
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
495
-1.86%
|
$232,155
$469.03 P/Share
|
|
Mar 01
2023
|
John E Gallina EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,781
+8.7%
|
-
|
|
Mar 01
2023
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
587
-1.04%
|
$275,303
$469.03 P/Share
|
|
Mar 01
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
12,008
+21.88%
|
-
|
|
Mar 01
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
607
-5.07%
|
$284,683
$469.03 P/Share
|
|
Mar 01
2023
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,297
+12.81%
|
-
|
|
Mar 01
2023
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,471
-2.21%
|
$1,158,899
$469.03 P/Share
|
|
Jan 03
2023
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,983
+32.47%
|
-
|